NCT03375294

Brief Summary

The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 18, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2020

Completed
3 months until next milestone

Results Posted

Study results publicly available

July 16, 2020

Completed
Last Updated

July 24, 2020

Status Verified

July 1, 2020

Enrollment Period

1.3 years

First QC Date

December 12, 2017

Results QC Date

June 26, 2020

Last Update Submit

July 22, 2020

Conditions

Keywords

PTSD

Outcome Measures

Primary Outcomes (1)

  • Number of Patients Who Met and Exceeded Response Criteria of Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

    Patients given CAPS-5 (Clinician Administered PTSD Scale for DSM-5), a 30-item structured interview that can be used to assess PTSD symptoms over the past week. For the CAPS-5 the minimum units are 0 and maximum units on the total scale are 80. The higher the number on the CAPS-5, the more severe the symptoms. Response was defined as at least a 12 point reduction on the CAPS-5

    Baseline and 1 week post inhalation

Study Arms (1)

Nitrous Oxide

EXPERIMENTAL

PTSD patients in this arm will receive a single inhalation dose of 50% nitrous oxide and 50% oxygen for 1 hour

Drug: Nitrous Oxide

Interventions

One hour inhalation of 50% nitrous oxide, an odorless, colorless gas FDA approved as an induction agent for dental sedation

Nitrous Oxide

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-80
  • Veterans of the United States Uniformed Services
  • primary diagnosis of PTSD
  • sufficient severity of PTSD symptoms
  • fluency in English
  • capacity to provide informed consent

You may not qualify if:

  • psychiatric or medical conditions that make participation unsafe
  • pregnant or nursing females
  • allergy to nitrous oxide

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Veterans Affairs Palo Alto

Palo Alto, California, 94304, United States

Location

Related Publications (1)

  • Varias A, van Roessel P, Parsiani M, Filippou-Frye M, Neylan TC, Nagele P, Yesavage J, Clark JD, Rodriguez CI. Does Nitrous Oxide Help Veterans With Posttraumatic Stress Disorder? A Case Series. J Clin Psychiatry. 2020 Jun 30;81(4):20l13393. doi: 10.4088/JCP.20l13393. No abstract available.

Related Links

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Nitrous Oxide

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen Compounds

Results Point of Contact

Title
Dr. Carolyn Rodriguez
Organization
Palo Alto Veterans Affairs

Study Officials

  • Carolyn Rodriguez, MD, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 18, 2017

Study Start

April 1, 2018

Primary Completion

July 31, 2019

Study Completion

April 5, 2020

Last Updated

July 24, 2020

Results First Posted

July 16, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations